J&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Johnson & Johnson seeks FDA authorization of Covid booster shot
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться